VĂN PHÒNG ĐẠI DIỆN ABBOTT LABORATORIES GMBH TẠI THÀNH PHỐ HÀ NỘI - Authorized Representative in Vietnam
Explore comprehensive authorized representative profile for VĂN PHÒNG ĐẠI DIỆN ABBOTT LABORATORIES GMBH TẠI THÀNH PHỐ HÀ NỘI through Pure Global AI's free Vietnam medical device database. This authorized representative represents 20 products registered in Vietnam from 9 manufacturers. Their regulatory history spans from Feb 10, 2024 to Invalid Date.
This page provides detailed insights including 5 recent product registrations, 5 manufacturer partners led by Abbott Ireland Diagnostics Division with 3 products, and comprehensive product portfolio analysis. Pure Global AI offers free access to Vietnam medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.
Phone
02437337486
vietnamregulatory@abbott.com
Qualitative Antibody IgM Control Material for Rubella Virus Testing
Registered: Nov 19, 2024
Everolimus-Eluting Coronary Artery Stent
Registered: Nov 14, 2024
Quantitative Test of CD3+/CD4+ Cells
Registered: Nov 14, 2024
IVD Quantitative HBeAg Test Kit
Registered: Nov 14, 2024
Ventricular Arrhythmia
Registered: Nov 06, 2024
Qualitative Antibody IgM Control Material for Rubella Virus Testing
Registered: Nov 19, 2024
Everolimus-Eluting Coronary Artery Stent
Registered: Nov 14, 2024
Quantitative Test of CD3+/CD4+ Cells
Registered: Nov 14, 2024
IVD Quantitative HBeAg Test Kit
Registered: Nov 14, 2024
Ventricular Arrhythmia
Registered: Nov 06, 2024
Qualitative Test for SARS-CoV-2 Antigen, Influenza A and/or Influenza B
Registered: Nov 02, 2024
IVD Department Qualitative Antibody Test for HTLV-I and HTLV-II
Registered: Nov 02, 2024
IVD Department, quantitative DNA testing of EBV
Registered: Nov 02, 2024
Qualitative Test Card for Legionella pneumophila Group 1
Registered: Nov 02, 2024
Standard Calibration Solution for Sirolimus Quantification Testing
Registered: Nov 02, 2024
The IVD Department quantitatively tests the protein of the perineuronal net with acidic properties (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1)
Registered: Nov 02, 2024
Urea Nitrogen Quantitative Testing Drug
Registered: Oct 30, 2024
Phosphorus Quantitative Testing Reagent
Registered: Oct 30, 2024
Amylase Quantitative Testing Drug
Registered: Oct 30, 2024
Amylase Quantitative Testing Drug
Registered: Oct 30, 2024
IVD Department Qualitative IgM Antibody Test for Rubella Virus
Registered: Oct 22, 2024
Sirolimus Quantitative Testing Drug
Registered: Oct 22, 2024
Albumin Quantitative Testing Drug
Registered: Oct 11, 2024
IVD Department, Quantitative Pepsinogen II Test
Registered: Oct 02, 2024
IVD Department, Quantitative Prolactin Test
Registered: Oct 02, 2024

